Nuvalent, Inc. (NUVL)
NASDAQ: NUVL · Real-Time Price · USD
101.95
-1.98 (-1.91%)
Feb 27, 2026, 4:00 PM EST - Market closed
Nuvalent Market Cap
Nuvalent has a market cap or net worth of $7.92 billion as of February 27, 2026. Its market cap has increased by 34.41% in one year.
Market Cap
7.92B
Enterprise Value
6.55B
1-Year Change
34.41%
Ranking
Category
Stock Price
$101.95
Market Cap Chart
Since the IPO on July 29, 2021, Nuvalent's market cap has increased from $795.96M to $7.92B, an increase of 894.66%. That is a compound annual growth rate of 65.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 26, 2026 | 8.07B | 3.32% |
| Dec 31, 2025 | 7.81B | 40.44% |
| Dec 31, 2024 | 5.56B | 20.68% |
| Dec 29, 2023 | 4.61B | 174.21% |
| Dec 30, 2022 | 1.68B | 82.83% |
| Dec 31, 2021 | 919.33M | 15.50% |
| Jul 29, 2021 | 795.96M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Praxis Precision Medicines | 9.41B |
| ImmunityBio | 9.40B |
| Arrowhead Pharmaceuticals | 8.87B |
| Bio-Techne | 8.81B |
| Vaxcyte | 8.61B |
| Axsome Therapeutics | 8.40B |
| Halozyme Therapeutics | 8.08B |
| Krystal Biotech | 8.05B |